Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

2002- present    Head, Laboratory of Infectious Disease Prevention,New York Blood Center,New York, NY

2011-present     Adjunct Professor, Epidemiology, Columbia University Mailman School of Public Health, New York, NY

Current Professional Summary:

Beryl A. Koblin, Ph.D. is an epidemiologist and Head of the Laboratory of Infectious Disease Prevention at the New York Blood Center and a faculty member at the Columbia University Mailman School of Public Health.  She is the Principal Investigator of Project ACHIEVE, a community-based HIV prevention research program in New York City.  Dr. Koblin’s research focus is to develop and test strategies to prevent HIV and conduct studies to better understand the changing epidemiology of HIV infection in urban areas in the US.  She has conducted community-based studies related to HIV infection among various populations, including men who have sex with men, injection drug users, and women and men at risk through heterosexual contact.  These studies have led to conducting large-scale clinical trials of HIV vaccines and behavioral interventions. Dr. Koblin has been the recipient of grants from federal and state agencies and foundations. Dr. Koblin received her Masters of Science and Ph.D. in Epidemiology with a concentration in infectious diseases from the Johns Hopkins University School of Hygiene and Public Health.


1982  Sc.M.      Epidemiology,JohnsHopkinsUniversitySchoolof Hygiene and Public Health,Baltimore,MD

1987  Ph.D.     Epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD

Selected Publications:
  1. Koblin BA, Egan JEE, Rundle A, Quinn J, Tieu H-V, Cerda M, Ompad DO, Greene E, Hoover DR, Frye V. Methods to Measure the Impact of Home Social and Sexual neighborhoods of Urban Gay Bisexual and Other Men who Have Sex with Men. PLoS ONE 8(10): e75878. doi:10.1371/journal.pone.0075878
  2. Koblin BA, Mansergh G, Chesney M, Coates T. Moving the bar to the right place: Positioning interventions in HIV prevention. AIDS Behav 10.1007/s10461-013-0607-9, 2013 [Epub ahead of print].
  3. Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, Del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, Elharrar V, Wheeler D and the HPTN 061 Protocol Team. Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061.PLoS One. 8(7):e70413. doi: 10.1371/journal.pone.0070413, 2013. PMCID:PMC3724810
  4. Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G, Frank I; on behalf of the HVTN 906 study team. Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: Longitudinal results of HVTN 906. J Acquir Immune Defic Syndr 63:239-44, 2013. PMCID:PMC3671573
  5. Koblin BA, Mayer KH, Noonan E, Wang C-Y, Marmor M, Sanchez J, Brown SJ, Robertson MN, Buchbinder SP. Sexual risk behaviors, circumcision status and pre-existing immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: Step Study. J Acquir Immune Defic Syndrome 60:405-413, 2012. PMCID:PMC3392543


An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management